Lundstrom

Lundstrom v. Young

Good Law
United States District Court, Southern District of CaliforniaMarch 21, 20233:18-cv-02856California352 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA 10 BRIAN LUNDSTROM, Case No.: 18-cv-2856-GPC

Plaintiff,

ORDER GRANTING LIGAND’S

v. MOTION FOR LEAVE TO AMEND

ANSWER AND DEFENSES TO

CARLA YOUNG, an individual;

SECOND AMENDED COMPLAINT

LIGAND PHARMACEUTICALS, INC.;

LIGAND PHARMACEUTICALS, INC.

[ECF No. 146] 401(K) PLAN; and DOES 1 through 20, Defendant. 18 On February 23, 2023, Defendants Ligand Pharmaceuticals and Ligand Pharmaceuticals, Inc. 401(k) Plan (“Defendants” or collectively “Ligand”) filed a Motion for Leave to Amend Answer and Defenses to the Second Amended Complaint. ECF No. 146. The Court set a briefing schedule. ECF No. 147. On March 17, 2023, Plaintiff Brian Lundstrom (“Plaintiff” or “Lundstrom”) filed a Non-Opposition. ECF No. 153. A party seeking to amend a pleading past a scheduling order deadline must show “good cause” for such relief. Fed. R. Civ. P. 16(b)(4). A court should grant leave to amend a pleading…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.